WHO Moves To Tackle Rampant Rise Of Diabetes

WHO Moves To Tackle Rampant Rise Of Diabetes
WHO chief Tedros Adhanom Ghebreyesus
WhatsApp
Facebook
Twitter
Telegram
LinkedIn
Print
The World Health Organization (WHO) on Wednesday announced that it would be turning its spotlight on the insulin market — and its domination by three Big Pharma giants in a move that seeks to tackle the rapid rise of diabetes.
The WHO joined the world to mark the 100-year anniversary of the discovery of insulin by launching a new Global Diabetes Compact aimed at boosting efforts to prevent diabetes and giving access to treatment to everyone who needs it.Speaking on Wednesday, WHO chief Tedros Adhanom Ghebreyesus said; ‘The need to take urgent action on diabetes is clearer than ever’.Speaking further he said, ‘The number of people with diabetes has quadrupled in the last 40 years,’ noting that ‘it is the only major non-communicable disease for which the risk of dying early is going up, rather than down’.

Read Also: Ramadan: WHO Warns Of Possible Covid-19 Surge

Tedros while addressing the crisis was particularly important in the face of the coronavirus pandemic, stressing that ‘a high proportion of people who are severely ill in hospital with Covid-19 have diabetes’.

The WHO says that about 422 million people worldwide have diabetes, most living in low-and middle-income countries, and 1.6 million deaths are directly attributed to diabetes each year.

The WHO said diabetes deaths had risen by 70 percent since 2000 and it was now the world’s ninth leading cause of death.

In 2019, the World Health Organization introduced a prequalification pilot programme aimed at bringing more manufacturers into the market to ‘help increase the availability of quality-assured insulin to countries that are currently not meeting demand’.

It said talks had begun with insulin manufacturers about ways to meet the growing demand ‘at prices that countries can afford’.

 

AFRICA DAILY NEWS, NEW YORK

WhatsApp
Facebook
Twitter
Telegram
LinkedIn
Print